fbpx

A Cancer Treatment Causes Side Effect of Night Vision

Research published in the Journal of Physical Chemistry Letters explained why photodynamic cancer therapy causes night vision in patients. Photodynamic therapy is a form of cancer treatment that uses light to destroy malignant cells. The interesting side effect patients have reported is night vision seen as silhouettes and outlines in the dark. Only now have researchers discovered the mechanics of this phenomenon.

The Mechanics of Night Vision

Photodynamic therapy involves injections of chlorin e6, a photosensitive compound. It’s the reaction between chlorin e6 and rhodopsin in the retinal photoreceptors rods that causes the apparent night vision to occur. Normally we see with visible light because of a compound in our eye called retinal being triggered by visible light. After triggering, retinal separates from rhodopsin, a light-sensitive protein in the retinas of our eyes, and an electrical signal is transmitted to our brain to interpret what we see. In the case of night vision seen by these cancer patients, infrared light combined with the chlorin e6 changes retinal in the same way it does under visible light conditions. “This explains the increase in night-time visual acuity,” chemist Antonio Monari, from the University of Lorraine in France tells CNRS (French National Centre for Scientific Research).

Using Molecular Simulation to Understand Chemical Reactions

The researchers used molecular simulation to model the movements of individual atoms as well as the breaking or creating of chemical bonds. It took several months of testing various simulations with millions of calculations before it was able to accurately model the chemical reaction caused by infrared radiation. “For our simulation we placed a virtual rhodopsin protein inserted in its lipid membrane in contact with several chlorin e6 molecules and water, or several tens of thousands of atoms,” Monari told CNRS.

Molecular simulation is a powerful tool and can help us better understand fundamental mechanisms. For example, it can help understand why certain DNA lesions are better repaired than others and help select the best therapeutic molecules by mimicking their interaction in a simulated model.

Reference: https://www.sciencealert.com/scientists-have-figured-out-how-a-cancer-treatment-gives-patients-night-vision

Featured Posts

EssilorLuxottica

EssilorLuxottica Creates Scientific Advisory Committee to Cccelerate Next Era of Innovation

EssilorLuxottica forms a new Scientific Advisory Committee of global experts to guide innovation in ophthalmology, AI, audiology, and life sciences.

Learn More
MIDO logo

MIDO 2026 Exhibitor List Now Live as “The Lens of Time” Exhibition Debuts

MIDO 2026 unveils its exhibitor list and debuts “The Lens of Time,” with 1,200 exhibitors, new installations, and expanded event programming.

Read more
World Council of Optometry

WCO Announces 2025 Election Results and New Global Leadership

The World Council of Optometry announces its 2025 election results and new leadership appointments, shaping the next phase of global optometric advocacy.

Read more
University Waterloo School of Optometry

WEI 2025: Education, Innovation, and Connection

The WEI Conference returns November 7–9, 2025 at the Hilton Toronto/Markham Suites with over 20 hours of COPE-accredited CE, the Woodruff and Bobier Distinguished Lectures, a strong speaker lineup, and a trade show featuring 30+ exhibitors — including VuePoint IDS at Booth #311.

Read more
Eye On the Industry podcast EOTI

Eye on the Industry Podcast Episode 6: Practice Growth Made Simple with Dr. Kiran Ramesh

Dr. Kiran Ramesh joins Eye on the Industry to share how systems, teams, and CEO mindset drive practice growth. Practical insights for independent eye care professionals.

Read more
EssilorLuxottica

EssilorLuxottica Creates Scientific Advisory Committee to Cccelerate Next Era of Innovation

EssilorLuxottica forms a new Scientific Advisory Committee of global experts to guide innovation in ophthalmology, AI, audiology, and life sciences.

Learn More
MIDO logo

MIDO 2026 Exhibitor List Now Live as “The Lens of Time” Exhibition Debuts

MIDO 2026 unveils its exhibitor list and debuts “The Lens of Time,” with 1,200 exhibitors, new installations, and expanded event programming.

Read More
World Council of Optometry

WCO Announces 2025 Election Results and New Global Leadership

The World Council of Optometry announces its 2025 election results and new leadership appointments, shaping the next phase of global optometric advocacy.

Read More
University Waterloo School of Optometry

WEI 2025: Education, Innovation, and Connection

The WEI Conference returns November 7–9, 2025 at the Hilton Toronto/Markham Suites with over 20 hours of COPE-accredited CE, the Woodruff and Bobier Distinguished Lectures, a strong speaker lineup, and a trade show featuring 30+ exhibitors — including VuePoint IDS at Booth #311.

Read More
Eye On the Industry podcast EOTI

Eye on the Industry Podcast Episode 6: Practice Growth Made Simple with Dr. Kiran Ramesh

Dr. Kiran Ramesh joins Eye on the Industry to share how systems, teams, and CEO mindset drive practice growth. Practical insights for independent eye care professionals.

Read More
EssilorLuxottica

EssilorLuxottica Creates Scientific Advisory Committee to Cccelerate Next Era of Innovation

EssilorLuxottica forms a new Scientific Advisory Committee of global experts to guide innovation in ophthalmology, AI, audiology, and life sciences.

Learn More
MIDO logo

MIDO 2026 Exhibitor List Now Live as “The Lens of Time” Exhibition Debuts

MIDO 2026 unveils its exhibitor list and debuts “The Lens of Time,” with 1,200 exhibitors, new installations, and expanded event programming.

Read more
World Council of Optometry

WCO Announces 2025 Election Results and New Global Leadership

The World Council of Optometry announces its 2025 election results and new leadership appointments, shaping the next phase of global optometric advocacy.

Read more
University Waterloo School of Optometry

WEI 2025: Education, Innovation, and Connection

The WEI Conference returns November 7–9, 2025 at the Hilton Toronto/Markham Suites with over 20 hours of COPE-accredited CE, the Woodruff and Bobier Distinguished Lectures, a strong speaker lineup, and a trade show featuring 30+ exhibitors — including VuePoint IDS at Booth #311.

Read more
Eye On the Industry podcast EOTI

Eye on the Industry Podcast Episode 6: Practice Growth Made Simple with Dr. Kiran Ramesh

Dr. Kiran Ramesh joins Eye on the Industry to share how systems, teams, and CEO mindset drive practice growth. Practical insights for independent eye care professionals.

Read more
EssilorLuxottica

EssilorLuxottica Creates Scientific Advisory Committee to Cccelerate Next Era of Innovation

EssilorLuxottica forms a new Scientific Advisory Committee of global experts to guide innovation in ophthalmology, AI, audiology, and life sciences.

Learn More
MIDO logo

MIDO 2026 Exhibitor List Now Live as “The Lens of Time” Exhibition Debuts

MIDO 2026 unveils its exhibitor list and debuts “The Lens of Time,” with 1,200 exhibitors, new installations, and expanded event programming.

Read more
World Council of Optometry

WCO Announces 2025 Election Results and New Global Leadership

The World Council of Optometry announces its 2025 election results and new leadership appointments, shaping the next phase of global optometric advocacy.

Read more
University Waterloo School of Optometry

WEI 2025: Education, Innovation, and Connection

The WEI Conference returns November 7–9, 2025 at the Hilton Toronto/Markham Suites with over 20 hours of COPE-accredited CE, the Woodruff and Bobier Distinguished Lectures, a strong speaker lineup, and a trade show featuring 30+ exhibitors — including VuePoint IDS at Booth #311.

Read more
Eye On the Industry podcast EOTI

Eye on the Industry Podcast Episode 6: Practice Growth Made Simple with Dr. Kiran Ramesh

Dr. Kiran Ramesh joins Eye on the Industry to share how systems, teams, and CEO mindset drive practice growth. Practical insights for independent eye care professionals.

Read more